Fundraising Fox

Venture-Backed Startups

79,952 companies with verified investor relationships.

Attendease

EventUp Planner is a cloud-based event planning and management platform that enables teams to organize, promote, and execute events from registration through post-event analytics. It serves enterprises managing multiple events across virtual, in-person, and hybrid formats with integrated features for ticketing, speaker coordination, agenda building, and attendee engagement.

1 investor

Attendly

1 investor

Attention

Attention provides AI-driven meeting analytics and coaching for sales teams, with direct integration into Microsoft Teams for recording, transcription, and performance analysis of sales conversations.

1 investor

Attention

Attention provides AI-powered sales tools for revenue teams, automating CRM data entry and providing real-time sales coaching to improve call outcomes and rep productivity. The platform integrates with major CRMs like Salesforce and HubSpot to help sales organizations close deals more effectively.

4 investors

Attentive

Attentive provides a multi-channel customer engagement platform that includes email, SMS, RCS, push notifications, and AI-powered lifecycle orchestration for direct-to-consumer brands. The company serves e-commerce and retail businesses seeking identity resolution and customer communication automation.

16 investors

Attentive Mobile

Attentive provides a mobile-first customer engagement platform that enables brands to orchestrate email, SMS, RCS, push, and AI-powered campaigns. The platform serves direct-to-consumer and ecommerce businesses seeking to drive customer engagement and revenue through unified messaging and identity resolution.

8 investors

Attenua

0 investors

Atterocor

0 investors

Attestiv

Provides AI-powered content detection and digital media forensics to validate the authenticity of media content.

2 investors

Attgeno

Developer of Supernitro, a first-in-class nitric oxide delivery therapy for pulmonary hypertension prevention and treatment.

2 investors

Atticus

Atticus provides document verification and audit trail capabilities for various document types including annual reports, presentations, and prospectuses. The platform serves teams and external reviewers who need controlled document access and verification.

2 investors

Atticus

Atticus is a law firm that helps people navigate legal issues and find appropriate legal representation, offering free consultations and matching clients with qualified lawyers who work on contingency basis.

7 investors

Atticus Ltd Liability

0 investors

Atticus Pharma

Atticus Pharma develops immunodermatology therapeutics using patented sustained-release technology for enhanced delivery to the viable epidermis. The company focuses on dermatological treatments leveraging its proprietary drug delivery platform.

2 investors

Attila Security

2 investors

attimet

AtTimeT builds predictive models for financial markets using mathematical approaches to anticipate large-scale market behavior. The company applies advanced intelligence techniques to asset management and financial decision-making.

1 investor

Attimis

Attimis builds data infrastructure that enables AI models to access unstructured data across distributed cloud, on-premise, and edge systems without copying or rearchitecting workflows. The platform serves AI development teams and enterprises managing data sovereignty and compliance constraints across multiple regions.

1 investor

Attio

Attio provides an AI-powered agent platform that automates prospecting and lead research for sales teams, enriching leads and qualifying them so sales representatives can focus on closing deals.

5 investors

Attirer

Web3 SEO and content marketing services for crypto, blockchain, DeFi, and NFT brands.

1 investor

Attis Finance

0 investors

ATTIS Trading Co - Barbur

0 investors

ATTIS Trading Co - Stark

0 investors

attivare

Attivare develops AI-powered personalized immunotherapy treatments using a proprietary biomaterial scaffold (ATTImmune) that delivers immune agonists directly to tumor microenvironments, aiming to reduce systemic toxicity in cancer and infectious disease treatment.

1 investor

Attivare Therapeutics

0 investors